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This study uses image analysis techniques for comparative analysis of the lung HRCT 
features and RT-PCR of 325 suspected patients to COVID-19 pneumonia. Our 
findings propose more caution in the interpretation of RT-PCR data, promoting, 
instead, also the quantification of age and sex-based risk factors using HRCT images. 
Statistical analysis of our methodology reveals a direct relation between intensity, 
skewness and kurtosis of the radiological features and the gender of patients. 
Moreover, we investigate the effect of the age of patients on the appearance of 
COVID-19 pneumonia in the HRCT images. We have also applied our methodology 
to investigate the effect of time on the severity of COVID-19 pneumonia within the 
lungs. Subsequently, we find a strong relationship between image analysis and the 
informed medical diagnosis asserted by the radiologists. Additionally, our results also 
indicate increase in the severity of lung infection in the first and second week after the 
onset of the SARS-CoV-2 symptoms. Thereafter, a gradual decrease in the lung 
damage is observed during the third week. The proposed image analysis methodology 
can be used as a simple complementary tool for infectious disease diagnostics as 
demonstrated in this study with an example of SARS-CoV-2 to provide better 
understanding of the disease for drug and vaccine development.  
 
1. Introduction 
In December 2019, Severe Acute Respiratory Syndrome of Coronavirus 2 (SARS-
CoV-2) appeared in Wuhan, China and shortly spread in the whole world [1]. Fever, 
dry cough, dyspnea, chest tightness and shortness of breath are common symptoms 
of SARS-CoV-2 which can lead to severe injury in the lungs and spreading of the virus 
to other organs such as  kidneys, heart, thyroid, and adipose tissue [2-6]. In particular, 
 
 
SARS-CoV-2 infect human respiratory epithelial cells through the interaction of viral 
protein and the Angiotensin Converting Enzyme 2 (ACE2) receptors abundantly 
present on the  cells forming the epithelial layers of the human respiratory tract [4], [6-
11]. Several factors such as age, sex and comorbidities lead to variation in 
complications associated with COVID-19 pneumonia, ranging from asymptomatic 
cases to patients with severely damaged lungs. [12–14]. The repercussions of these 
symptoms and associated risk factors can lead to health complications in long term 
and in many cases these symptoms can be fatal in short term, if left unaddressed. As 
such the development of intervention medicine (e.g. specific drug) is still in pre-mature 
stage, while vaccination may have cause unwanted changes in the body in long term 
[15] . Therefore, precise detection and continuous informed monitoring of COVID-19 
infection is urgently required to be established, one possible route can be through the 
customization/improvement in analysis of techniques routinely used in medical 
industry.  
 
Current detection methods which are widely used for diagnosis of SARS-CoV-2 are 
Reverse Transcription Polymerase Chain Reaction (RT-PCR), chest X-ray, High 
Resolution Computed Tomography (HRCT) scans, and the detection of some common 
biomarkers in the blood [16–20]. However, recent studies reported that the positive 
rate of RT-PCR is between 30% to 60% [20–23]. This suggests that at initial stage of 
the disease, many infected cases may not be detected due to the low sensitivity of 
RT-PCR. In parallel, recent clinical investigations have revealed the advantages of 
Chest-HRCT (hereafter referred as HRCT) to demonstrate typical radiological features 
in the patients suspected to COVID-19 pneumonia, consisting both positive and 
negative RT-PCR results [20], [22–26]. However, due to the infancy of the research in 
the HRCT and RT-PCR analysis of COVID-19 pneumonia, in addition to the limitation 
of HRCT such as low specificity, need of high level skills (combination of clinical and 
image development expertise) in  HRCT image analysis and low sensivtity of HRCT 
for early stage rapid disease detection [27–29], new and simple image analysis are 
required to enhance the capaciaty of HRCT and RT-PCR, For instance, understanding 
the association between risk factors and the findings of the HRCT in combination with 
RT-PCR may lead to more specific detection than the current state of art in the use of 




In this context, we report clinical results of HRCT and RT-PCR of 325 patients 
suspected with COVID-19 pneumonia and evaluate the advantages of HRCT in 
comparison to the RT-PCR test. Furthermore, based on the quantitative and statistical 
image analysis on the HRCT data, we found the relation between sex and age as main 
risk factors in the enhancement of the disease and features identified in the HRCT.  
In order to investigate our hypothesis, RT-PCR and HRCT was conducted in the 
patients and new image analysis was performed in the patient data. Starting from 
HRCT outcomes, RT-PCR results have been analyzed and associated to the 
assertions made using image analysis. The obtained results are discussed with 
respect to age and sex-based risk factors to quantify with the severity of damage in 
the lungs due to the COVID-19 pneumonia. 
 
2. Methods 
The institutional review board of Iran University of Medical Science (ethics code IR-
IUMS.REC.1399.347) have approved this retrospective study and the requirement to 
obtain a written informed consent was waived. This study has been performed on the 
suspected patients to SARS-CoV-2 infection who came to Fateme Alzahra hospital in 
Isfahan province as the reference hospital for COVID-19 disease in Najaf Abad city in 
first COVID-19 pandemic (13 March-27 April 2020). 
 
1. Chest HRCT Protocol 
All HRCT were performed using a GE scanner (Optima CT540, UK). A low-dose 
institutional protocol was applied with the main scanning parameters as follows: tube 
voltage: 100kVp; tube current: 10-202 mAs; automatic exposure control; slice 
thickness = 3.75 mm. CT images were acquired at full inspiration with the patient in 
supine position, and without administration of intravenous contrast medium. 
 
2. RT-PCR  
Real-time RT-PCR assay have been performed in the hospital with samples obtained 
from endotracheal aspirate using nasopharyngeal/oropharyngeal swabs. The RT-PCR 
kits that were approved by WHO (Name of manufacturer: Sansure, China and 
Dangene, China) were used for COVID-19 tests. The cycle threshold (CT) value of 39 
is used in this work as per the guidelines given the kits. The kits identify nucleocapsid, 
RNA dependent RNA polymerase (RdRp) and ORF1 viral genes of COVID-19. If one 
 
 
gene was positive, the test was repeated, and then if same gene was detected again, 
a positive result was reported otherwise from patient test was repeated again to 
confirm negative/positive outcome. 
 
3. Image Analysis  
Two radiologists (F.A. and R.S., with 6 and 7 years of experience in interpreting chest 
CT images, respectively) blinded to RT-PCR results reviewed all HRCT images and 
decided on positive or negative HRCT findings by consensus. The epidemiologic 
history and clinical symptoms (fever and/or dry cough) were available for both readers. 
The radiologists classified the HRCT scan (according to Radiological Society of North 
America (RSNA) classification) as, typical, indeterminate, atypical and negative for 
COVID-19 pneumonia. A description of main HRCT features and lesion distribution 
has been performed. 
 
4. Statistical and Quantitative Image Analysis 
Quantitative and statistical image analysis was performed using ImageJ software, a 
java-based image processing tool developed by National Institute of Health (NIH) 
(https://imagej.nih.gov/ij/download.html). Essentially individual HRCT images were 
uploaded in the ImageJ software and then converted to 8-bit format. Following image 
conversion to 8-bit, lung cross section area was selected manually in each image 
using draw polygon command. This area was then analysed by measuring the average 
gray value within the selection. Here the measurand is the sum of gray values of all 
the pixels in the selected area divided by the number of pixels, represented as mean 
intensity, reported in arbitrary units (a.u.). To check the empirical formula, refer to the 
documentation of ImageJ in the aforementioned link. This suggests that the presence 
of cloudy regions in the HRCT image (such as the one corresponding to the ground 
glass opacity) will show higher values of mean intensity as compared to the normal 
regions of the lung. It should be noted that higher values of mean intensity imply more 
damage to the lungs. In addition, we also calculated the kurtosis and skewness of all 
the gray values within the lung selection area of the HRCT image. The skewness 
represents the distortion in the normal distribution of the data and kurtosis is a measure 
of distributions’ tail relative to the centre of the data distribution. If the curve is shifted 
to the left or to the right from an ideal normal distribution of the data, it is said to be 
positive or negative skewed respectively. Similarly, if the tail of the data set under 
 
 
analysis extends further than the ideal normal distribution, then it is said to have 
negative kurtosis and if the tails of the dataset are within the boundaries of an ideal 
normal curve, it has a positive kurtosis. Here, the physical meaning of skewness and 
kurtosis can be extended to highlight the severity of the damage in the lungs. In 
particular, more negative skewness is associated with degree of opacity in the lungs 
as it indicates more gray pixels in the selected area of the image. Similarly, negative 
kurtosis indicates that the spread of the gray pixels in the region under selection is 
wider than the ideal normal distribution, which can be attributed to the large surface 
covered by the opaque regions in the lungs. 
 
5. Case selection 
The diagram of our case selection is given in figure 1. In our patients selection we 
follow Fleischner Society criteria [30]. According to HRCT findings and RSNA 
classification [31], patients were classified in four groups: patients with typical 
appearance of COVID-19, intermediate appearance of COVID-19 pneumonia, atypical 
for COVID-19 pneumonia and negative for COVID-19 pneumonia (other diseases 
appearance or patients with normal HRCT). Depending on the RT-PCR of the patients 
within each group, every group is classified into two subgroups: patients for whom RT-
PCR was conduction and for whom RT-PCR was not conducted. At the last stage, 
each subgroup is classified into two sections: patients with positive results of RT-PCR 
and patients with negative RT-PCR results. However, in this study, retrospective 
analysis of only RT-PCR positive patients has been performed, and other data of 
negative RT-PCR test are classified as subsidiary data.  
 




6. ImageJ Study Design 
 
General steps involved within the analysis are highlighted in figure 2. The flowchart in 
this scheme shows operation protocol for the analysis of HRCT images and 
subsequent analysis using parameters of mean, skewness and kurtosis.  
 
Figure 2. Steps to compute mean, skewness and kurtosis using ImageJ analysis. 
 
It should be noted that the step 5 in the protocol will analyze complete image (including 
scale bar and text within standard HRCT image) and therefore specific HRCT area for 
measurement must be manually selected for analysis. This analysis was performed 
on all HRCT images individually (as each image had different lung sizes) and the data 
generated was grouped into different categories according to the diagnosis of the 
radiologists (positive/negative COVID-19, sex and gender). Data from individual 
categories are reported in the figures within results and discussion section where data 
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3. Results and Discussions 
3.1 HRCT and RT-PCR analysis 
From 325 patients with low dose HRCT performed on them, 123 cases had typical 
appearance of COVID-19 pneumonia, out of which 44 cases (35.8%) were women 
and 79 cases (64.2%) were men. The range of their age was between 24 to 96 years 
and the mean age was 57.78 years. From these 123 patients 6 of them (4.87%) also 
had cardiomegaly (3 women, 3 men), 18 patients (14.63%) pleural effusion (2 
women ,16 men), 6 patients (4.87%) lung nodule or mass (3 women, 3 men), 3 patients 
(2.43%) hyperinflation (1 woman ,2 men), 4 patients (3.25%) emphysema or 
bronchiectasia or fibrosis (1 woman ,3 men) and a man (0.81%) with pulmonary artery 
dilatation. 
  
Among the 123 infected cases, 18 patients (14.6%) in the range of 34-96 years passed 
away due to the infection. From the 123 patients which show typical appearance of 
COVID-19 pneumonia on HRCT, 78 patients were also tested by RT-PCR technique. 
The RT-PCR test of 45 patients (57.6% of 78 patients) was found to be positive and 
33 patients (42.3% of 78 patients) were found to be negative. No RT-PCR test was 
conducted in the rest of the 45 patients, and they were treated solely based on the lab 
serology and HRCT data. It should also be noted that in the 45 patients with both 
positive HRCT and RT-PCR outcomes, 11 patients were women and 34 patients were 
men with the age range of 28-96 years and mean age of 64.84 years for both sexes. 
From 325 patients, intermediate HRCT signs were observed in 48 patients, among 18 
of them RT- PCR test has been performed and other 30 cases were treated by 
considering clinical symptoms and serology. From 325 patients, atypical HRCT for 
COVID-19 pneumonia were observed in 25 patients, among 13 of them RT-PCR test 
has been performed (4 patients positive) and other cases were treated by considering 
clinical symptom and serology. 
 
From the pool of all patients (325 patients) 129 patients HRCTs were negative for 
COVID-19 pneumonia, among them other diseases feature on HRCT including 
cardiomegaly, hyperinflation, mediastinal mass, emphysematous changes were 
observed in 68 patients (without imaging evidence of SARS-COV-2 infection) and 61 
patients had normal HRCT.  However, the RT-PCR test has been performed only for 
 
 
14 patients out of which 2 patients showed positive results. Table 1 summarize the 
results. 
Table 1. Demographic information of patients with typic COVID-19 appearance on HRCT and/or 
positive results for RT-PCR test. 










appearance on HRCT  
79  44  24-96  57.78   18  73.38 
 
Patient with typical 
covid-19 appearance 
on HRCT and RT-PCR+  
34  11  28-96  64.84 
 
9  76.66  
Patient with RT-PCR+ 
(typical  HRCT or not)  
42  15  28-96  65.92  11  79.54  
 
Among 325 patients, without considering HRCT results, the RT-PCR test has been 
performed for 122 patients. In total, 57 patients had positive result in RT-PCR test, 
where 15 of them were women and 42 patients were men. For both women and men, 
the age range was 28-96 years, with a mean age value of 65.92 years. Out of 57 
patients, 11 patients between 53-92 years (mean age: 79.54 years), with positive RT-
PCR tests, died. 
 
In this study we focus on the 57 patients, with RT-PCR positive. Among these patients, 
crazy paving appearance were seen in 18 of them (patchy: 8 patients, continues: 10 
patients), Ground Glass Opacities (GGO) is seen in 18 patients, peribronchiovascular 
involvement has been observed in one patient, consolidation is seen in 13 patients 
(with air space appearance in 5 of them) and halo sign is observed in 1 patient. In 
addition, mix appearance is observed in 4 patients, normal HRCT is reported for 1 and 
cardiomegaly without other involvement has been seen for 1 patient. Figure 3 shows 




Figure 3. Transverse CT scans a) Low dose lung HRCT shows multiple patchy ground 
glass opacities in both lungs as sign of COVID-19 pneumonia. b) Low dose lung HRCT 
shows cardiomegaly and diffuse crazy paving appearance in lungs suggesting COVID-
19 pneumonia. c) Low dose lung HRCT shows cardiomegaly and air space 
consolidation in RML, suggesting lobar pneumonia. d) Low dose lung HCRT shows a 
consolidation patch in RML with surrounding ground glass opacities (halo sign). e) 
Low dose lung HRCT showed cardiomegaly, bilateral peribronchiovascular 
consolidation, pleural effusion, DDX was pulmonary edema and Covid-19 pneumonia. 
Note for all of cases the results of RT-PCR test are positive. 
 
We also observed parenchymal involvement in 55 patients using HRCT; in particular 
the unilateral lung parenchymal involvement was seen in 6 of them while bilateral lung 
parenchymal involvement is observed in 49 of them. The involvement with anterior 
dominancy was observed in 9 patients and the involvement with posterior dominancy 
was seen in 46 patients. The main affected lobe of 12 patients was upper lobe, 5 
patients was middle lobe and 38 patients was lower lobe of the lungs. The main 
infected affected area in 3 patients was in the centre of the lungs, in other 35 patients 
it was at the peripheral parts of the lung while rest of the 17 patients the infection was 
continuous in nature. Pleural effusions also existed in 20 patients. Furthermore, 
cardiomegaly was observed in 5 cases of 57 cases. In 1 patient, pulmonary trunk 
dilatation was seen.  
  
Out of 57 patients, 11 patients passed away. In these 11 patients the continuous crazy 






them and the consolidation appearance was seen in one of them.  The 
peribronchovascular was seen in one patient too. Ten patients had bilateral 
involvement and for 1 dead patient the unilateral involvement was observed and 5 of 
them had pleural effusion. Figure 4 and Tables 2 and 3 summarized the appearance 
of lung HRCT in the patients with positive RT-PCR which recovered (figure 4a) or died 
(figure 4b). Figure 4c summarized the percentage of patients identified as positive 
HRCT based on their gender and their RT-PCR results (positive or negative). As it can 
be seen from figure 4c, the positive rate of RT-PCR assay is about 55%, which is 
consistent with that in a previous report [20]–[23]. It means the results of RT-PCR 
should be interpreted with caution. 
 
Table 2. Summary of COVID-19 appearance on lung HRCT in patients with positive PCR test. 
COVID-19 appearance on lung HRCT Number (percentage) 
 
 Crazy paving appearance 
Continues :10 (17.54%)  
Patchy :8 (14.03%)  
Ground glass opacities  18 (31.57%)  
Alveolar consolidation  
Non-alveolar consolidation  
5 (8.77%)  
8 (14.03%)  
Peribronchiovascular  1 (1.7%)  
Halo sign  1 (1.7%)  
Mix  4 (7.01%)  
Other diseases  1 (1.7%)  
Normal  1 (1.7%)  
Unilateral side 
Bilateral side  
6 (10.9%)  
49 (89.9%)  





12 (21.81%)  
5 (9%)  
38 (69.09%)  





3 (5%)  
35 (63.63%)  
17 (30.9%)  




9 (16.36%)  
46 (83.63%)  




Table 3. COVID-19 appearance on lung HRCT in dead patients with positive RT-PCR. 




Continuous crazy paving 
appearance  
6 (54.54%)  
Ground glass opacities  3 (27.27%)  
Consolidation  1 (9.9%)  
Peribrenchiovascular  1 (9.9%)  
Unilateral side 
Bilateral side  
1 (9.9%)  
10 (90.9%)  
Pleural effusion  5 (45.45%)  
 
 
 Figure 4. Summary of lung HRCT appearances and patients with positive HRCT. a) 
Covid-19 appearance on lung HRTC in patients with positive PCR. b) Covid-19 
appearance on lung HRCT in dead patients with positive PCR. c) Statistical data of 
patients with positive HRCT classified based on the gender, recovery/died, positive 
and negative RT-PCR test results. 
 
3.2 Risk factor evaluation of lung HRCT features and PCR 
In order to compare the sensitivity of HRCT with RT-PCR and study the relation 
between age and gender as important risk factors, quantitative image analysis is 
performed for the radiological features observed in HRCT. The statistical analysis was 
computed using non-parametric Mann-Whitney U test for data presented in figure 5a-
c. For all other data multiple comparison, using 2-way ANOVA test, Tukey test with 
pooled variance is conducted to compare the means of each data test while 
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< 0.05 was considered statistically significant, with 95% confidence interval. Figure 5a 
shows the statistical results of comparison between cases with positive HRCT and 
both positive and negative RT-PCR. As seen from results, there is no significant 
differences between positive and negative RT-PCR in the intensity, skewness and 
kurtosis calculated from HRCT images. Moreover, it is observed that RNA virus 
detection cannot completely reply on the RT-PCR as shown by HRCT. RT-PCR 
negative hits found to be 42.3% for 33 patients out of all 78 patients tested with positive 
HRCT. It can be explained by the lack of sensitivity, insufficient stability, and relatively 
long processing of RT-PCR test [20], [32]. Other factors which can affect the accuracy 
of RT-PCR are specimen source (lower or upper respiratory tract), performance of kits 
and the sampling time window which is related to the time of disease development 
with which RT-PCR test has been conducted. In order to study the relation between 
severity of damages and appearances of COVID-19 pneumonia in the lungs with the 
gender and age as two main risk factors in SARS-CoV-2 disease [12–14] , we have 
performed another image analysis. The results are given in figures 5d to j. The HRCT 
mean (5a), skewness (5b) and kurtosis (5c) show higher intensity values in RT-PCR 
positive compared to RT-PCR false negative. As it is depicted, generally the mean 
intensity for males is higher than females independent of RT-PCR results (5d). 
Furthermore, for both positive and negative RT-PCR results, the mean intensity of 
males is higher than the females. This is in agreement with recent RNA-sequential 
and single cells analysis which has been performed on SARS-CoV-2 infected samples 
to describe higher susceptibility in male than female to COVID-19 pneumonia [4], [33]. 
According to report of [4], significant correlations between ACE2 expression levels 
with CD8+ T cell enrichment level (0.20<r<0.68) and interferon response signature 
(0.32≤r≤0.82) in males were detected; on contrary female patients show a negative 
correlation, r=-0.3 and (-0.26<r<-0.20), respectively [4]. Moreover, significant 
differences are observed for false negative PCR in males and HRCT (figure 5e and 
5f). Based on the definition of skewness and kurtosis it can be deduced that for 
negative RT-PCR results of male, the cloudy regions in the HRCT images were 
distributed wider and not concentrated in specific parts of lung. This result can be 
helpful to understand the reason of false negative RT-PCR results while the 
appearance of SARS-CoV-2 infection identified in the HRCT images. In addition, 
comparison of the results associated to the age factor shows that there was no 
 
 
significant difference between appearance of COVID-19 pneumonia in the HRCT 
images for the patients older and younger than 50 years.  
 
 
Figure 5. Results for 123 patients which reported all symptoms of COVID-19 infection. 
All HRCT positive patients for COVID-19 showed mixed results. Images a-c show no 
statistically significant differences for the whole population at RT-PCR and HRCT 
scans (without sex & age categorization): a- intensity, b-skewness and c-kurtosis. 
Images d-f) shows categorization of patients into male and female: d- intensity, e-
skewness and f-kurtosis.  g-i) segregation of patients into ages less than 50 and 
greater than equal to 50: g- intensity, h-skewness and i-kurtosis.  j) Shows statistical 
analysis using t-test and 2-way ANOVA (Tukey) performed to highlight statistical 
 
 
relevance of the data. Here, the symbol * indicates the qualitative level of significance 
(P < 0.05) in the differences of mean values within subfigures a-i. 
 
3.3 Time-based stages of COVID-19 infection 
Finally, in figure 6, the examples of COVID-19 pneumonia in different times (in different 
patients) during the course of infection were analyzed using HRCT images. It can be 
seen that there is a direct correlation between the results of image analysis and 
findings by the radiologists. For the patients 1 to 3 where the second images are 
obtained after 7, 4 and 3 days, respectively, the severity of lung damage is increased 
as explained with details in the figure while for the patient with second image after 36 
days, the severity was significantly decreased, and the patient was recovered from 
hospital (see P1-4 in figure 6). These results are in agreement with the findings of [34-
35], which explain in the first and second weeks after symptom onset, the extent of 




Figure 6. a) Transverse CT scans [P1]: patient with low dose lung HRCT showing 
bilateral continuous ground glass opacities with septal thickening (crazy paving 
appearances) more severe in left lung is an indicator COVID-19 pneumonia. After 7 
days opacities became denser (alveolar consolidation). [P2]: Patient with low dose 
lung HRCT showing bilateral patchy ground glass opacities (GGO), suggestive of 
Covid-19 pneumonia. After 4 days opacities become continuous and with septal 
thickening (crazy paving appearances). [P3]: Patient with low dose lung HRCT 
showing multiple peripheral patchy GGO, typical for Covid-19 pneumonia. After 3 days, 
number of patches are increased and the size of patches become larger. [P4]: Patient 
low dose HRCT showed bilateral peripheral and posterior ground glass patches with 
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with ground glass appearance. b) intensity, c) skewness and d) kurtosis of HRCT 
images of four patients at different days.  
 
It is worthy to mention that this analysis has been performed from the patients at the 
early days of COVID-19 pandemic when sufficient information and facilities were not 
well available for the COVID disease diagnosis. For example, at that time the RT-PCR 
kits were not sufficient, and it took time to provide the results (3-5 days). Additionally, 
due to a large number of patients visiting the hospital were suspected with COVID-19, 
the main goal was to provide a quick detection and avoid the spread of virus in the 
province. Even though the HRTC has a low specificity and it is not considered as the 
standard method to detect COVID-19, using HRCT as a complementary method for 
detection and diagnosis of COVID-19 beside RT-PCR, can compensate the low 
sensitivity of RT-PCR, especially where additional RT-PCR tests are required for 
critical patients. In long term, this approach could be improved by using advanced 
image analysis tools such as machine learning and artificial intelligence to enhance 
the low specificity of HRCT. Also, development of advanced biosensing tools, such as 
those which detect viruses directly or indirectly via antibodies, may address the 
specificity and sensitivity issues of HRCT and RT-PCR. Therefore, these results  serve 
as important findings for utilizing simple analytical methods applied to clinical images 
for identification of risk factors associated with the disease under detection.   
 
4. Conclusions 
So far in the literature and clinical practice, the HRCT technique for the diagnosis 
COVID-19 is considered inferior to RT-PCR for the initial detection of the disease i.e. 
when typical symptoms of the disease start to appear. However, RT-PCR, though 
rapid, well-established and more sensitive than HRCT, is prone to false hits even in 
the severe COVID-19 cases as shown by work. We also demonstrate that for such 
cases, the chest HRCT has higher sensitivity than RT-PCR test (with 55.6% accuracy 
in detecting virus) for the diagnosis of COVID-19 pneumonia. Therefore, the most 
significant conclusion of our study from clinical perspective suggests that HRCT 
should be used as a mandatory complementary technique alongside RT-PCR for 
patients with severe symptoms of COVID-19 disease, especially when RT-PCR shows 
negative results for the disease. Moreover, the image analysis method used in our 
work is simple and can easily be implemented within clinical analysis protocols for 
 
 
HRCT to determine risk associated with the disease. Future studies could include 
developing opensource online image analysis tool for our current methodology. The 
work also severs as a benchmark report for researchers developing HRCT image 
contrast dyes for the detection of pathogen in lungs. Several researchers developing 
advanced biosensors based on spike protein detection or antibody against protein 
detection [18] may also find our work useful for underdstanding limitations of both 
HRCT and RT-PCR techniques used for the detection of COVID-19. This will 
eventually lead to either more optimized use of the established tools in clinical practice 
or fast development of new sensitive tools for the diagnosis of viral diseases. The work 
also encourage more collaborative work between clinicians and technology 
development (such as image analysis tool demonstrated here) to enhance further 
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